NCT02879617 2024-01-05A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer PatientsAcademic Thoracic Oncology Medical Investigators ConsortiumPhase 2 Completed47 enrolled 34 charts